According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform
The collaboration brings a seamless digital experience to more formulators worldwide
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Subscribe To Our Newsletter & Stay Updated
